An increasing array of B-cell targeting approaches may aid clinicians in managing the cycles and flares of lupus, according ...

The first CAR-T cell therapy was developed and approved by the FDA in 2017 to treat relapsed or refractory B-cell precursor ...

Monoclonal B-cell lymphocytosis is when your body produces an elevated number of identical B cells. In some cases, it can develop into chronic lymphocytic leukemia. Monoclonal B-cell lymphocytosis ...

B cells are immune cells that help your body fight infections. CAR T cells target a protein that is on the surface of both cancer cells and B cells. Sometimes they can destroy B cells while ...

The transcriptional repressor B-cell lymphoma 6 (BCL6) plays a central role in the development and progression of various B-cell malignancies, particularly diffuse large B-cell lymphoma (DLBCL), where ...

If you or a loved one has diffuse large B-cell lymphoma (DLBCL ... change them in a lab so that they target lymphoma cells, and then put them back into your body, where they go to work killing ...